Marginal Contribution of Pathogenic <em>RAD51D</em> Germline Variants to Pakistani Early-Onset and Familial Breast/Ovarian Cancer Patients

CONCLUSION: No pathogenic RAD51D variant was identified in the current study. Our study data suggested a negligible association of RAD51D variants with BC/OC risk in Pakistani …